Search Results 7371-7380 of 26444 for oral

  1. A Study of ONO-7475 in Patients With Acute Leukemias - Mayo Clinic

    ... oral or parenteral contraceptives and/or intrauterine devices) during the entire duration of the study and for 4 months after final administration of study drug ...

  2. Surgery - Doctors - Mayo Clinic

    Christopher F. Viozzi, M.D., D.D.S.. Oral and Maxillofacial Surgeon. Rochester, MN ...

  3. Celebrating the gift of life: Cousins raise awareness for organ donation on National Donor Day - Mayo Clinic News Network

    This National Donor Day, an annual observance dedicated to spreading awareness and education about organ, eye and tissue donation, M.

  4. Spinal cord tumor - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

  5. New strategy controls pain after Chiari malformation surgery - Mayo Clinic

    Oral opioids are typically administered, and there is a known risk of persistent opioid use after surgery. Although liposomal bupivacaine has been used to ...

  6. Publications - Paul M. McKie, M.D. - Mayo Clinic

    Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure. Circulation. 2005 Aug 9; 112(6): ...

  7. Sodium phenylacetate and benzoate (intravenous route) - Side effects & uses - Mayo Clinic

    Your doctor will give you or your child a few doses of this medicine until your condition improves, and then switch you to an oral medicine that works the same ...

  8. A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss - Mayo Clinic

    For females, an acceptable method (Pearl Index < 1%) would be to agree to use implants, injectables, combined oral contraceptives, some intrauterine devices, or ...

  9. A Study to Evaluate Ribociclib Plus Letrozole to Treat Cancer of the Ovary, Fallopian Tube or Peritoneum - Mayo Clinic

    Direct-Acting Oral Anticoagulants (DOACS) are permitted. Patient is currently receiving or has received systemic corticosteroids ≤ 2 weeks prior to ...

  10. Efficacy and safety of subcutaneous dupilumab in participants with asthma/asthmatic wheeze aged 2 to <6 years - Mayo Clinic

    Severe asthma with the need for chronic oral/systemic corticosteroid use ( > th continuous) at the time of screening enrollment. History of a systemic ...